Prostate Cancer
BNT324-03 A Phase III, randomized, open-label trial of BNT324 versus docetaxel with prednisone/prednisolone in metastatic castration-resistant prostate cancer
- Details
ClinicalTrials.gov ID:
NCT07365995
Diagnosis Type:
NA
USOR Number:
- Address
,
P: